Second Genome
Second Genome to help drive development of Gilead therapies in potential $1.5bn deal
April 8, 2020Research and Development Gilead, Second Genome, pharma
Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
